한국 7세 아동에서 프로보콜린으로 평가된 기관지 과민성의 위험 인자 및 절단값

한국 7세 아동에서 프로보콜린으로 평가된 기관지 과민성의 위험 인자 및 절단값

Risk Factors and Cutoff value of Bronchial Hyperresponsiveness Assessed by the Provocholine in Korean 7-year-old General Population

(구연):
Release Date : 2017. 10. 26(목)
Sungsu Jung1, Dong In Suh2, So-Yeon Lee1, Ji-Sun Yoon1, Hyun-Ju Cho1, Young-Ho Kim3, Song-I Yang4, Ji-Won Kwon5, Gwang Cheon Jang6, Yong Han Sun7, Sung-Il Woo8, You-Sook Youn9, Kang Seo Park10, Hwa Jin Cho11, Myung-Hee Kook12, Hye Ryoung Yi12, Hai Lee Chung13, Ja Hyeong Kim14, Hyung Young Kim15, Jin A Jung16, Hyang-Ok Woo3 , Soo-Jong Hong1
Ulsan University Asan Medical Center Department of Pediatrics1
Seoul National Univesity Children's Hospital Department of Pediatrics2
Gyeongsang National University Hospital Department of Pediatrics3
Hallym University Sacred Heart Hospital Department of Pediatrics4
Seoul National Univesity Bundang Hospital Department of Pediatrics5
National Health Insurance Corporation Ilsan Hospital Department of Pediatrics6
Gachon University Gil Medical Center Department of Pediatrics7
Chungbuk National University Hospital Department of Pediatrics8
The Catholic University of Korea Daejeon St. Mary's Hospital Department of Pediatrics9
Presbyterian Medical Center Department of Pediatrics10
Chonnam National University Hospital Department of Pediatrics11
Gwangju Veterans Hospital Department of Pediatrics12
Daegu Catholic University Medical Center Department of Pediatrics13
Ulsan University Hospital Department of Pediatrics14
Pusan National University Yangsan Hospital Department of Pediatrics15
Dong-A University Hospital Department of Pediatrics16
정성수1, 서동인2, 이소연1, 윤지선1, 조현주1, 김영호3, 양송이4, 권지원5, 장광천6, 선용한7, 우성일8, 윤유숙9, 박강서10, 조화진11, 국명희12, 이혜령12, 정혜리13, 김자형14, 김형영15, 정진아16, 우향옥3 , 홍수종1
울산의대 서울아산 어린이병원 소아청소년과1
서울대학교 어린이병원 소아청소년과2
경상대학교병원 소아청소년과3
한림대학교 성심병원 소아청소년과4
분당서울대학교병원 소아청소년과5
국민건강보험공단 일산병원 소아청소년과6
가천대 길병원 소아청소년과7
충북대학교병원 소아청소년과8
가톨릭대학교 대전성모병원 소아청소년과9
예수병원 소아청소년과10
전남대학교병원 소아청소년과11
광주보훈병원 소아청소년과12
대구가톨릭대학교병원 소아청소년과13
울산대학교병원 소아청소년과14
양산부산대병원 소아청소년과15
동아대학교병원 소아청소년과16

Abstract

Background/Aims : Recently, an FDA-approved methacholine chloride ( Provocholine®) was introduced to Korea and widely used in the clinical practice. We aimed to evaluate the prevalence, risk factors and cutoff value of bronchial hyperresponsiveness (BHR) to Provocholine® in Korean 7-year-old general population. Methods : We recruited 2078 subjects in the initial cohort of the Panel Study on Korean Children. Among the subjects, 1577 mother-child dyads completed the 2015 annual follow-up, and 642 children visited the regional hospitals. We performed a standard spirometry, skin prick test and the bronchial provocation test via Provocholine® as well as a detailed history and physical examination in 16 regional hospitals. 559 children reliably completed bronchial provocation test. Results : Asthma was ever-diagnosed in around 7.7% of children, but the current asthma (wheezy episode in the last 12 months + diagnosed asthma by physicians) was found in 3.2%. Heightened BHR ( PC20 16 mg/mL) was observed in 25.8 % of children. The response dose ratio (RDR), a log-transformed continuous marker of airway responsiveness, was significantly elongated in current asthmatics than the others ( P=0.022). Moreover, there was a trend of increasing median RDR values across the groups of control, allergic rhinitis only, asthma only, and the combined allergic rhinitis and asthma ( P=0.001). Finally, the risk factors for current asthma were allergy rhinitis diagnosis ( P=0.018), history of bronchiolitis before the age of 3 ( P=0.004), recent use of analgesics/antipyretics ( P=0.027) and maternal history of asthma ( P=0.005). On the other hand, the risk factors for BHR were atopic dermatitis diagnosis and current dog ownership. The cutoff value of BHR to provocholine for the diagnosis of asthma in children was 5.8mg/mL (sensitivity : 47.1%, specificity : 87.4%). Conclusion : BHR assessed by Provocholine would give us useful clinical information. In the future, it is necessary to disclose the natural course of asthma and BHR through long-term follow up.

Keywords: Bronchial hyperresponsiveness, Asthma, Risk factors